Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 03 04:00PM ET
27.49
Dollar change
-0.50
Percentage change
-1.79
%
Index- P/E- EPS (ttm)-2.32 Insider Own2.14% Shs Outstand65.90M Perf Week0.66%
Market Cap1.81B Forward P/E- EPS next Y-1.59 Insider Trans0.00% Shs Float64.49M Perf Month2.23%
Income-152.81M PEG- EPS next Q-0.50 Inst Own29.14% Short Float2.33% Perf Quarter-3.68%
Sales582.71M P/S3.11 EPS this Y-109.72% Inst Trans-50.01% Short Ratio7.66 Perf Half Y-0.18%
Book/sh48.48 P/B0.57 EPS next Y-370.48% ROA-3.19% Short Interest1.50M Perf Year-27.29%
Cash/sh57.24 P/C0.48 EPS next 5Y47.44% ROE-5.65% 52W Range24.16 - 42.46 Perf YTD-32.37%
Dividend Est.- P/FCF- EPS past 5Y- ROI-4.77% 52W High-35.25% Beta0.22
Dividend TTM- Quick Ratio9.95 Sales past 5Y16.83% Gross Margin96.76% 52W Low13.78% ATR (14)0.81
Dividend Ex-Date- Current Ratio10.13 EPS Y/Y TTM-3035.40% Oper. Margin-37.29% RSI (14)49.57 Volatility2.19% 2.61%
Employees1123 Debt/Eq0.00 Sales Y/Y TTM-7.12% Profit Margin-26.22% Recom2.64 Target Price36.19
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-1098.46% Payout0.00% Rel Volume0.30 Prev Close27.99
Sales Surprise-11.40% EPS Surprise-379.33% Sales Q/Q-59.71% EarningsOct 30 AMC Avg Volume196.40K Price27.49
SMA201.26% SMA50-2.89% SMA200-4.82% Trades Volume59,310 Change-1.79%
Date Action Analyst Rating Change Price Target Change
Nov-20-24Downgrade Kepler Hold → Reduce
Sep-09-24Initiated Leerink Partners Market Perform $24
Aug-02-24Downgrade Raymond James Outperform → Mkt Perform
Mar-28-24Downgrade BofA Securities Neutral → Underperform $41 → $31
Mar-07-24Resumed Morgan Stanley Equal-Weight $38
Aug-24-23Downgrade Citigroup Buy → Neutral
May-05-23Upgrade Raymond James Mkt Perform → Outperform
Jan-23-23Upgrade Jefferies Underperform → Hold $49 → $47.20
Nov-07-22Downgrade Raymond James Outperform → Mkt Perform
Sep-09-22Downgrade Morgan Stanley Overweight → Equal-Weight $80 → $61
Nov-05-24 04:01PM
Oct-30-24 04:01PM
Oct-07-24 01:00AM
Sep-30-24 04:01PM
Sep-16-24 04:01PM
04:01PM Loading…
Sep-03-24 04:01PM
Aug-23-24 01:00AM
Aug-20-24 04:01PM
Aug-01-24 04:01PM
04:01PM
Jun-25-24 05:53AM
Jun-14-24 04:01PM
May-30-24 04:01PM
04:01PM
May-16-24 04:01PM
04:01PM Loading…
May-15-24 04:01PM
May-06-24 10:47AM
May-02-24 04:01PM
Apr-30-24 04:01PM
Apr-24-24 09:35AM
Apr-04-24 04:01PM
Apr-03-24 09:35AM
Mar-28-24 04:01PM
Mar-26-24 04:01PM
Mar-18-24 09:35AM
Mar-17-24 05:20PM
Feb-24-24 08:30AM
Feb-22-24 04:01PM
04:01PM
Feb-15-24 04:01PM
07:00AM Loading…
Feb-05-24 07:00AM
Jan-31-24 04:01PM
Jan-04-24 04:01PM
Jan-03-24 04:01PM
04:01PM
Jan-02-24 01:00AM
Dec-19-23 04:01PM
Dec-09-23 12:00PM
Dec-07-23 04:01PM
Nov-06-23 10:32AM
07:45AM
Nov-02-23 04:01PM
Oct-30-23 04:01PM
Sep-19-23 04:01PM
Aug-28-23 04:01PM
Aug-03-23 04:01PM
Jun-15-23 04:01PM
Jun-12-23 04:01PM
Jun-05-23 04:01PM
May-23-23 04:01PM
May-22-23 04:01PM
May-05-23 04:01PM
May-04-23 04:01PM
May-02-23 04:01PM
Apr-26-23 04:01PM
Apr-25-23 04:01PM
Mar-30-23 04:30PM
Mar-23-23 04:01PM
Mar-20-23 04:01PM
Feb-27-23 04:01PM
Feb-23-23 04:01PM
Feb-09-23 04:01PM
Feb-08-23 04:01PM
Jan-10-23 04:01PM
Jan-03-23 04:01PM
Dec-23-22 04:01PM
Dec-22-22 04:01PM
Dec-16-22 09:55AM
Dec-13-22 01:00AM
Dec-08-22 09:35AM
Nov-11-22 07:15AM
Nov-08-22 04:01PM
Nov-04-22 04:01PM
Nov-03-22 04:01PM
Nov-02-22 07:15AM
Oct-17-22 01:30AM
Oct-06-22 04:01PM
Oct-03-22 04:01PM
Sep-29-22 03:59PM
Sep-27-22 04:01PM
Sep-13-22 10:21AM
Aug-29-22 04:01PM
Aug-24-22 04:01PM
Aug-18-22 04:01PM
Aug-08-22 04:01PM
Aug-04-22 04:01PM
Jun-29-22 09:40AM
Jun-22-22 06:39AM
Jun-21-22 04:03PM
Jun-20-22 04:01PM
Jun-09-22 09:55AM
Jun-02-22 09:40AM
Jun-01-22 04:01PM
May-25-22 04:01PM
May-24-22 09:35AM
May-16-22 09:40AM
May-11-22 09:47AM
May-09-22 03:30PM
May-06-22 04:01PM
May-05-22 04:01PM
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.